About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
HISTORICAL VOLUME
Historical
Volume
Ajanta Pharma Ltd.
BSE Code
532331
ISIN Demat
INE031B01049
Book Value
310.16
NSE Code
AJANTPHARM
Dividend Yield %
1.16
Market Cap
301519.63
P/E
32.22
EPS
74.91
Face Value
2
Exchange :
BSE
NSE
Period From :
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
DEC
2025
2024
Period To :
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
DEC
2025
2024
Date
Open Price(Rs.)
High Price(Rs.)
Low Price(Rs.)
Close Price(Rs.)
Volume
Turnover
24-Oct-2025
2405.55
2433.85
2389.00
2413.40
1816
4371559
23-Oct-2025
2453.90
2483.95
2404.00
2416.30
2392
5789874
21-Oct-2025
2440.00
2460.00
2440.00
2453.85
105
257459
20-Oct-2025
2438.55
2457.20
2420.00
2435.45
3224
7851462
17-Oct-2025
2447.75
2459.85
2413.05
2438.50
2268
5519477
16-Oct-2025
2401.25
2500.00
2401.25
2474.20
1490
3656864
15-Oct-2025
2413.95
2438.90
2389.00
2409.05
3302
7964405
14-Oct-2025
2405.50
2410.30
2380.90
2392.45
2118
5068804
13-Oct-2025
2412.20
2442.35
2393.30
2417.75
2262
5459313
10-Oct-2025
2401.40
2459.00
2401.40
2434.45
2574
6266217
09-Oct-2025
2414.95
2453.50
2391.15
2421.60
9132
22010153
08-Oct-2025
2492.05
2492.05
2388.00
2408.55
3576
8643829
07-Oct-2025
2431.45
2465.70
2415.05
2461.60
1206
2939868
06-Oct-2025
2380.55
2438.00
2380.55
2431.35
1986
4795648
03-Oct-2025
2429.45
2429.45
2380.00
2402.65
1878
4504414
01-Oct-2025
2397.80
2439.25
2394.35
2398.70
1836
4438200
Page
1
of
1
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.